XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma
Clinical trial NCT03355612 · UNKNOWN
Trial details
- NCT number
- NCT03355612
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2020-12-20
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.